KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

CareDx (CDNA) Finished Goods (2016 - 2025)

Historic Finished Goods for CareDx (CDNA) over the last 13 years, with Q3 2025 value amounting to $9.5 million.

  • CareDx's Finished Goods rose 7549.22% to $9.5 million in Q3 2025 from the same period last year, while for Sep 2025 it was $9.5 million, marking a year-over-year increase of 7549.22%. This contributed to the annual value of $4.8 million for FY2024, which is 3173.87% up from last year.
  • Per CareDx's latest filing, its Finished Goods stood at $9.5 million for Q3 2025, which was up 7549.22% from $8.4 million recorded in Q2 2025.
  • In the past 5 years, CareDx's Finished Goods registered a high of $9.5 million during Q3 2025, and its lowest value of $2.4 million during Q1 2021.
  • For the 5-year period, CareDx's Finished Goods averaged around $4.2 million, with its median value being $3.7 million (2023).
  • The largest annual percentage gain for CareDx's Finished Goods in the last 5 years was 12978.85% (2021), contrasted with its biggest fall of 4682.91% (2021).
  • CareDx's Finished Goods (Quarter) stood at $3.9 million in 2021, then dropped by 24.26% to $3.0 million in 2022, then increased by 23.5% to $3.7 million in 2023, then soared by 31.74% to $4.8 million in 2024, then surged by 97.92% to $9.5 million in 2025.
  • Its last three reported values are $9.5 million in Q3 2025, $8.4 million for Q2 2025, and $4.4 million during Q1 2025.